Narcolepsy Market is expected to drive huge growth during 2019-2027 owing to rising technique in diagnosis of chronic sleep disorder

Key factors driving the market are rising prevalence of sleep related disorders, emerging local pharmaceutical & biopharmaceutical companies, and increasing awareness regarding neurological disorders. However, factors such as side effects and risks associated with narcolepsy medications and delayed diagnosis or misdiagnosis of narcolepsy are likely to restrain the market growth to a certain extent.

According to new research report Narcolepsy Market is expected to reach US$ 4,537.9 Million in 2027 from US$ 2,026.8 Million in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027. The report highlights the trends prevalent in the global narcolepsy market and the factors driving the market along with those that act as deterrents to its growth.

Get Sample Copy of the Report at - http://tiny.cc/z6uw9y

The Asia Pacific narcolepsy market is expected to grow at highest rate during the forecast period owing higher number of research & development and increasing investments on sleep related neurological disorders. In addition, emergence of new local players with competitive drug portfolio are expected to fuel the market growth in Asia Pacific region.

Some of the prominent players operating in narcolepsy market are:

- Bioprojet
- Teva Pharmaceutical Industries Ltd.
- Jazz Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
- Arena Pharmaceuticals, Inc.
- Shire (Acquired by Takeda)
- Ligand Pharmaceuticals, Inc.
- Novartis AG, Mylan N.V.
- Shionogi Inc.

Key Elements that the report acknowledges:

⦁ Market size and growth rate during forecast period.

⦁ Key factors driving the “Narcolepsy” market.

⦁ Key market trends cracking up the growth of the “Narcolepsy” market.

⦁ Challenges to market growth.

⦁ Key vendors of “Narcolepsy” market.

⦁ Detailed SWOT analysis.

⦁ Opportunities and threats faces by the existing vendors in Global “Narcolepsy” market.

⦁ Trending factors influencing the market in the geographical regions.

⦁ Strategic initiatives focusing the leading vendors.

⦁ PEST analysis of the market in the five major regions.

Strategic Insights

Strategic acquisition and product launches were observed as the most adopted strategy in global narcolepsy industry. Few of the recent product launch and acquisitions are listed below:

2018: Jazz Pharmaceuticals announced FDA approval of Xyrem (sodium oxybate) for the treatment of cataplexy or excessive daytime sleepiness in pediatric narcolepsy patients

2019: Takeda Pharmaceutical Company Limited acquired Shire plc to expand its geographic footprint and leading position in Japan and the U.S.

2018: Jazz Pharmaceuticals announced FDA acceptance of supplemental new drug application for Xyrem (sodium oxybate) to treat cataplexy and excessive daytime sleepiness in pediatric narcolepsy patients.

The market players are focused towards bringing new and innovative products and services to sustain their position in the market. For instance, in October, 2018, Officials with the FDA have approved Jazz Pharmaceuticals' Xyrem (sodium oxybate) for the treatment of cataplexy and excessive daytime sleepiness in pediatric patients aged 7 to 17 years with narcolepsy. The drug had previously been approved for use in adult patients. The developments performed by the companies are helping the market to grow in the coming years.

Avail Discount on this Report at - http://tiny.cc/k7uw9y

Market Segmentation Analysis:

Global Narcolepsy Market - By Type

• Narcolepsy with Cataplexy
• Narcolepsy without Cataplexy
• Secondary Cataplexy

Global Narcolepsy Market – By ProductSodium Oxybate

• Central Nervous System (CNS) Stimulants
• Antidepressants

Global Narcolepsy Market – By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies

Purchase this Report Click Here - http://tiny.cc/e8uw9y

Key Reasons to buy this Report:

• Learn about the driving factors, affecting the market growth.

• Imbibe the advancements and progress in the market during the forecast period.

• Understand where the market opportunities lies.

• Compare and evaluate various options affecting the market.

• Pick up on the leading market players within the market.

• Envision the restrictions and restrains that are likely to hamper the market.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.